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WHAT THIS PAPER ADDS
 This article demonstrates that the size of an abdominal aortic aneurysm (AAA) depends on when during the cardiac cycle this
parameter is measured and calls for the need for the standardisation of measurements of AAA diameters during the cardiac cycle e
especially when diagnosing AAA, as is necessary for screening and surveillance.a r t i c l e i n f o
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Aim: The objective of the study was to evaluate the impact of the cardiac cycle on ultrasound
measurements of abdominal aortic aneurysm (AAA) diameters.
Methods: In total, 603 AAAs detected by screening were investigated with respect to the maximal systolic
and diastolic anterioreposterior aortic diameters during the cardiac cycle using recorded ultrasound
video sequences.
Results: On average, the systolic AAA diameter was 41.60 mm, and the diastolic AAA diameter was
39.63 mm with a paired mean difference at 1.94 mm (p < 0.0001). No association between aneurysmal
size and difference in systolic and diastolic size was noted.
The mean difference and variability between two observers, one measured during peak-systole and the
other measured during end-diastole, was 2.65 and 2.21 mm, respectively, as compared with 0.86 and
1.52 mm, respectively, when both were measured during the peak of systole. The intraobserver
variability was 0.94 during systole, 1.18 during diastole and 1.94 mm when systole and diastole
measurements were combined.
Conclusion: The lack of a standardised measurement of the AAA diameter during the cardiac cycle is
a potential major contributor to the variability in ultrasonography measurements.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Exact valid ultrasound (US) measurement of the maximal
diameter of abdominal aortic aneurysms (AAAs) is becoming more
and more important. First, it is the method of ﬁrst choice for
diagnosis in suspected cases and population-based screening pro-
grammes. Second, it is used to monitor small AAAs for expansion to
sizes that require repair. Third, it is increasingly used to express
regression or progression (shrinkage or growth) in cases under
surveillance after the patient has undergone endovascular aneu-
rysm repair (EVAR) or for scientiﬁc reasons as the end-point in
pathophysiologic and biomarker studies, as well as in pharmaco-
logical interventional trials seeking to impair progression.tions on this paper, please go
ndholt).
ciety for Vascular Surgery. PublisheWhile validation studies of US measurement of the aorta
diameter describe an intraobserver SD of 1.3 mm, the interobserver
variation reportedly reaches 5 mm or as high as 8 mm.1e9 In our
previous randomised screening study, as now, strict standards were
used, and the right-angled external maximal anterioreposterior
(AP) diameter during the peak of systole (as determined by longi-
tudinal view) was recorded and used as the basis for AAA surveil-
lance. Blinded validation studies of the examinations showed an SD
of the intraobserver variability of measurements below 0.5 mm3,10
and an interobserver variability of 1.46 mm.
The four randomised population-based screening studies
(Viborg, Chichester, Western Australia and Multicentre Aneurysm
Screening Study (MASS)) displayed some discrepancies with
respect to the methodology used for US measurement of AAA.
Today, a right-angled external measurement of the aorta (in the
longitudinal view) is generally accepted as the gold standard.11d by Elsevier Ltd. All rights reserved.
Table 1
Maximal aneurysmal diameters measured in systole or diastole.
Mean SD Paired t-test Proportional
difference (%)
95% CI P-value
Systolic
Max AP (mm)
41.60 11.51 1.94/41.60 4.7%
Diastolic
Max AP (mm):
39.63 11.54 1.94/39.63 4.9%
Difference in
Max AP Size (mm)
1.94 1.428 1.82; 2.06 <.001
Mean of the systolic and diastolic diameter (mm)
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Figure 1. Scatterplots of the mean and the difference in maximal systolic and diastolic
diameters.
N. Grøndal et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 30e33 31Some reports on US12e15 demonstrate the neck distensibility of
AAAs in relation to endovascular treatments and found pulsative
wall motions (PWMs) of approximately 1mm. Interestingly, similar
to computed tomography (CT) and magnetic resonance studies
(MR), this distensibility decreased in most studies following
endovascular intervention. Nonetheless, variability with respect to
the cardiac cycle seems to be overlooked in discussions of how to
diagnose and monitor AAAs.
Recent CT and MR angiography studies have developed tracking
systems to compensate for PWM to perform exact vascular
measurements in the cardiac cycle. Most studies report distensi-
bility rates from 1 to 5 mm16e21; however, as above, the focus is on
AAA-neck distensibility, EVAR treatment and research in the ﬁeld of
EVAR endoleak.
In 2008, a very large randomised screening trial, The Viborg
Vascular (VIVA) Screening trial began enrolment of more than
50 000 65e74-year-old men. Cases with an AAA diagnosis
(deﬁnition: þ30 mm) had a video recording of their AAA taken for
the measurement of maximal AP external during systole and
diastole, respectively.
Consequently, the aim of this study was primarily to quantify
the difference in size when measuring diameter during systole
versus diastole, and thus indirectly, demonstrate the potential
variability of the measurements concerning AAA when measure-
ments are not standardised according to the cardiac cycle. Second,
we aimed to describe the intra- and interobserver variability of the
size measurements based on peak-systole and end-diastole when
values were not standardised with respect to the cardiac cycle.
Materials and Methods
All 50 309 men aged 65e74 years in the mid-region of Denmark
were enrolled in the VIVA trial. Half (25 095) were randomised to
vascular screening with ankleebrachial systolic blood pressure
index (ABI) measurement and US scan of the aorta at their local
hospital. The Logiq e (General Electrics) was used for US assess-
ments, and AAA visualisation was performed according to a stand-
ardised protocol.22 In addition, a questionnaire regarding lifestyle
parameters and medical and smoking status was completed by the
study participants.
AAAs were diagnosed in 603 study participants. Of these, 104
AAAs were above 50 mm; these patients were transferred for a CT
scan, and members of the local vascular surgical department made
the decision as to whether repair or surveillance at their depart-
ment should be recommended. The remaining 499 small- to
middle-sized AAAs were offered annual follow-up control scans as
part of the screening programmes. All 603 AAAs were submitted to
video-recorded US scanning to determine the maximal diameters
in relation to the cardiac cycle. Measurements of the maximal
systolic and maximal diastolic AP diameters were performed at the
bedside using the cinematic replay function on the US scanner
throughout the pulsatile cycle.
Twenty-ﬁve AAAs were randomly chosen for measurements of
the maximum diameters. The AP diameter was determined in
diastole and systole by two experienced sonographers, who were
blinded to each other’s measurements, to establish the inter- and
intraobserver variability of size measurements.
The study was approved by the local scientiﬁc ethical
committee, and all participants provided their informed consent.
Statistical Analysis
The size difference between measurements obtained during
systole and the diastole was tested with the paired t-test and
Pearson’s correlation analysis. The association between AAA sizeand maximal diastolic size was tested by univariate and multivar-
iate linear regression analyses adjusting for smoking, systolic blood
pressure, ABI < 0.9, diabetes and the use of statins. Data were
judged for normality using probability plots and one-sample Kol-
mogoroveSmirnov tests.
The inter- and intraobserver variability were calculated as twice
the SD of the mean difference provided by Spearman correlation
analyses and plots addressing systematic errors, as suggested by
Bland and Altman.Results
The 603 AAA cases were all men aged between 65 and 74 years
with mean systolic blood pressure of 157.07 mmHg (SD 21.10);
41.1% were current smokers, 29% had an ABI < 0.9, 10.9% had dia-
betes mellitus and 53.3% used statins.
The systolicmaximal AAAdiameter ranged from30.0 to 111.4mm,
with an average of 41.6 mm, while the diastolic maximal AAA dia-
meter ranged from 28.9 to 108.3 mm, with an average of 39.63 mm.
The paired difference averaged 1.94mm (p< 0.0001). This difference
accounts for close to 5% of the measured diameter (Table 1).
The Pearson correlation between the systolic and diastolic
diameters was 0.99 (p< 0.001). Fig.1 presents the plot of themeans
and the differences in diameter (r ¼ 0.01, p ¼ 0.76). There was
no sign of a linear correlation between the difference in size
measurements and mean maximal diameter (Fig. 2). Adjusting for
Figure 2. Scatterplot of the difference in maximal AAA size and systemic systolic blood
pressure.
N. Grøndal et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 30e3332smoking, systolic blood pressure, ABI < 0.9, diabetes and the use of
statins did not reveal any association between mean AAA size and
the difference in size during systole and diastole. However, systolic
blood pressure was a negative independent predictor of size
difference (p ¼ 0.015); the lower the systolic blood pressure, the
higher the size difference between systole and diastole. However,
the association seems weak in spite of the signiﬁcance (Fig. 2). In
addition, the presence of lower limb atherosclerosis (p¼ 0.078) and
present diabetes mellitus (p ¼ 0.098) were not signiﬁcantly asso-
ciated with any reduction in the size difference (Table 2).
Asmentioned above, the inter- and intraobserver variability data
were collected in a blinded fashion for 25 randomly chosen AAAs.
The absolute mean difference between the two observers during
systole and diastole was 0.86 mm for both; the interobserver vari-
ability was 1.52 and 1.89 mm, respectively (Table 3). Consequently,
the 95% conﬁdence interval (CI) of themeasurements during systole
and diastole was 2.38 and 2.75 mm, respectively. The mean differ-
ence between the two observers when one was measured during
systole,while the otherwasmeasured during diastole and vice versa
was 2.65 mm. The interobserver variability was 2.21 mm. Conse-
quently, the mean difference of the measurements without stand-
ardisation was three times higher, and the maximal 95% CI of the
measurements without standardisation was 4.86 mm, or twice as
high as measurements standardised to the peak of systole.
The intraobserver variability was 0.94 mm during systole,
1.18 mm during diastole and 1.94 mm for measurements taken
during systole and diastole (Table 3).Table 2
Multiple linear regression analysis using the difference in maximal AAA size in systole and
systolic blood pressure, current smoking, peripheral arterial disease (PAD), the use of sta
Dependent variable: difference in
maximal AAA size
B Std. error
(Constant) 3.113 .566
Mean max size (mm) .005 .005
Systolic blood pressure (mmHG) .007 .003
Current smoking .046 .102
PAD .258 .147
Use of statin .113 .128
Diabetes mellitus .339 .204Discussion
Although elasticity and compliances studies have examined
differences in AAA diameter during the cardiac cycle, quantiﬁcation
of this potentially important source of variability of the measure-
ments has not been performed. Furthermore, there is no stand-
ardised approach as to the timing of these measurements with
respect to the cardiac cycle. This study quantiﬁes, for the ﬁrst time,
themagnitude of the difference in AAA size during the cardiac cycle
and demonstrates that up to 2 mm (5%) of the AAA size depends on
when during the cycle it was measured. Considering that the
usually reported variability of the measurements is approximately
5 mm (see above), this source could be a very important factor to
standardise to minimise measurement variability. Today, absolute
aortic size and regression or progression of AAA size is an
increasingly important clinical observation: AAA size must be
considered as a biomarker. Biomarkers serve several functions:
(1) To distinguish between diseased and healthy individuals. A
difference of 2 mm inﬂuences the validity of a US scan in
diagnosing an AAA in screening programmes as well as the
identiﬁcation of whom to refer for CT scan and preoperative
evaluation. Increased variability will increase the numbers of
false negative ﬁndings in screening programmes and cases
referred for CT scan and evaluation but sent back to the
surveillance programme due to insufﬁcient size of the aneu-
rysm. In the present VIVA trial, 20% of the AAAs diagnosedwere
below 32 mm; half of these (10%) would have been considered
normal, if measurements were performed during the diastole
instead of at the peak during systole. Similarly, 10% of those
above 55 mm would have been considered to be below the
threshold for surgery (55 mm) if only a US was used, leaving
them at risk of rupture prior to the next control scan.
(2) A pathophysiological biomarker is a marker that can be used to
identify risk factors. AAA size over time, calculated as growth
rate, is such a marker. It may not be relevant for post-EVAR, but
it is certainly relevant for monitoring AAA size to identify risk
factors for progression including potential biomarkers.
(3) In this context, the third principal purpose of biomarkers is to
monitor treatment. So far, no established medical treatment
to impair progression has been developed, but research is
ongoing.
While standardisation in US measurements can easily be
adapted, as suggested in this article, conventional CT scans require
sophisticated technology to solve this problem and are not widely
used in daily clinical work.
A strength of the present study is the large population-based
sample size, use of a strict protocol with standards for recording
and measuring maximal diameter during systole and diastole,
respectively, and the use of three identical portable US scanners,
each operated by only two observers who were uniformly traineddiastole, respectively, and maximal AAA size measured in end-diastole adjusted for
tins and diabetes mellitus.
P-value 95% Conﬁdence interval for B
Lower bound Upper bound
.000 2.001 4.225
.410 .015 .006
.015 .013 .001
.654 .155 .247
.079 .030 .546
.378 .139 .365
.098 .739 .062
Table 3
Intra- and interobserver variation in the measurement of 25 randomly selected cases of abdominal aortic aneurysms.
Mean difference (mm) SD 95% C.I. of the mean difference P-value
Lower Upper
Intraobserver variation (N ¼ 50)
Systoleesystole .07200 .46513 .20419 .06019 .279
Diastoleediastole .00400 .58969 .16359 .17159 .962
Systoleediastole 1.41400 .96766 1.22200 1.60600 .001
Interobserver variation (N ¼ 25)
Systoleesystole .10417 1.15701 .59273 .38440 .663
Diastoleediastole .21667 1.27234 .75393 .32059 .413
Systoleediastole 2.53958 1.34017 2.15044 2.92873 .001
N. Grøndal et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 30e33 33and supervised to perform the US examinations. In relation to
generalisability and applicability, this could also be a weakness
because common practice often involves additional staff to perform
examinations (and thereby increasing variability). Traditionally,
radiologists and clinicians who perform ultrasonography never
broadly agree on a clear guideline, and even radiologists have
different approaches to performing measurements. The four
randomised AAA screening studies differed in several ways meth-
odologically; for example, the MASS trial used the internal
(luminal) diameter. As with all diagnostics, the use of ultrasonog-
raphy is expanding, as is the number of operators who perform it in
clinical practice. Cardiovascular consultants use ultrasonography at
the bedside, and residents in such ﬁelds receive mandatory basic
training on how to perform such examinations. In other words, the
skills are learnt, but a new common guideline seems crucial,
especially to adjust for the phases of the cardiac cycle. Furthermore,
a cinematic replay option on the US equipment must be used to
ensure the correct display of diameters in the pulsatile cycle.
Another weakness could be the lack of ultrasonic echo-tracking of
the wall to identify systole and diastole precisely.23 However, such
potential information bias would be directed towards the null
hypothesis of no difference, which may obscure an even higher
difference than reported. Consequently, the development of stan-
dards for when to measure the maximal aneurysmal diameter
during the cardiac cycle is strongly suggested.Acknowledgments
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